The following is a concise summary of promising potential biomarkers for CTCL: (1) The high expression of KIR3DL2/CD158k, primarily found on NK cells and a minor subset of CD4 and CD8 T cells, is observed in all CTCL variants. The gene discussed is KIR3DL2; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.